OrthoPediatrics Corp.

KIDS · NasdaqGM · Stock · Healthcare
$23.05
+3.60% today
Delayed price,

What OrthoPediatrics does

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Key facts

Sector
Healthcare
Industry
Medical Devices
Market cap
$601.8M
P/E (ttm)
—
Forward P/E
-32.5
Dividend yield
0.00%
Beta
0.99
Profit margin
-15.7%
Employees
602
Headquarters
Warsaw, IN, United States
Exchange
NasdaqGM

Performance

1 Month
+5.6%
3 Months
+20.0%
6 Months
+37.6%
1 Year
+33.7%
5 Years
-58.6%
$14.4252-week range$26.74
Biggest setback — last 12 months
-19.0%
23 Feb 2026 → 23 Mar 2026
Fell from $19.17 to $15.52 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+65.3%
23 Mar 2026 → 17 Aug 2026
Ran from $15.52 to $25.65 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$20.57 (-10.8%)$23.05$25.83 (+12.1%)
3 Months$18.92 (-17.9%)$23.05$28.08 (+21.8%)
6 Months$17.44 (-24.4%)$23.05$30.47 (+32.2%)
12 Months$15.53 (-32.6%)$23.05$34.20 (+48.4%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 39.5%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 302,369 shares at $21.01 — Squadron Capital LLC, 10% Owner · 2026-09-11
Sold 302,369 shares at $21.01 — Pritzker Jennifer N., 10% Owner · 2026-09-11
Sold 22,500 shares at $23.35 — Squadron Capital LLC, 10% Owner · 2026-09-04
Sold 22,500 shares at $23.35 — Pritzker Jennifer N., 10% Owner · 2026-09-04
Sold 336,831 shares at $23.10 — Squadron Capital LLC, 10% Owner · 2026-09-01
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.